Mohan Vineeth, Jones Ralph C, Drake Almond J, Daly Patrick L, Shakir K M Mohamed
Endocrinology and Metabolism Department, National Naval Medical Center, Bethesda, Maryland 20889-5600, USA.
Thyroid. 2005 Feb;15(2):170-5. doi: 10.1089/thy.2005.15.170.
Papillary thyroid carcinoma (PTC) commonly metastasizes to cervical lymph nodes. Distant metastases are unusual with the lungs most frequently involved. Well-differentiated thyroid carcinoma very rarely presents with metastases to the spleen. This is the case of a 25-year-old man with a history of PTC (1.4 cm primary; no capsular invasion and negative lymph node metastases). One year after initial surgery, recurrent disease was found in multiple neck nodes by central neck dissection. Whole body scan (WBS) following a therapeutic ablation dose of 150 mCi I(131) revealed mediastinal metastases. Computerized axial tomography (CT) of the chest one year later showed no gross mediastinal or pulmonary disease. However, multiple large splenic lesions were incidentally noted. Evaluation by ultrasound (US) showed lesions to be solid echogenic masses without remarkable Doppler characteristics to suggest vascular tumors. US-guided percutaneous fine-needle aspiration biopsy (FNAB) of one lesion was nondiagnostic. After withdrawal from Levothyroxine, serum TSH was >100 mU/L with a thyroglobulin of 9.4 ng/mL and negative anti-thyroglobulin antibodies. Diagnostic WBS revealed faint splenic uptake but was otherwise unremarkable. Following treatment with 192 mCi I(131), WBS demonstrated increased activity in the mediastinum as well as in the spleen suggesting mediastinal and splenic metastases. Contrast CT of the abdomen showed multiple low-attenuated heterogeneously enhancing splenic masses, normal liver and no intra-abdominal lymphadenopathy. The largest mass (4.5 x 3.5 cm) was exophytic and in close proximity to the splenic capsule. Despite the serum thyroglobulin of only 9.4 ng/mL, the finding of I(131) accumulation within solid splenic masses led to a preoperative diagnosis of thyroid carcinoma metastases. To establish the diagnosis and to remove the risk for splenic rupture, a laparoscopic splenectomy was performed. Histopathologic analysis showed large littoral cell angiomas (LCA). False-positive radioiodine scintigraphy in the setting of PTC involving a vertebral hemangioma has been reported. To our knowledge, this is the first case that describes multiple angiomas mimicking metastatic thyroid carcinoma to the spleen. In one-third of all cases reported, LCA co-exists with various visceral organ cancers or malignant lymphoma. This is the first report of an association between LCA and thyroid carcinoma.
甲状腺乳头状癌(PTC)通常转移至颈部淋巴结。远处转移并不常见,最常累及肺部。高分化甲状腺癌极少出现脾脏转移。本文报道了一例25岁男性患者,有PTC病史(原发灶1.4 cm;无包膜侵犯,淋巴结转移阴性)。初次手术后一年,通过中央区颈部清扫发现多个颈部淋巴结复发疾病。给予150 mCi I(131)治疗性消融剂量后进行的全身扫描(WBS)显示纵隔转移。一年后的胸部计算机断层扫描(CT)显示无明显纵隔或肺部疾病。然而,偶然发现多个脾脏大病灶。超声(US)评估显示病灶为实性高回声团块,无明显多普勒特征提示血管肿瘤。对一个病灶进行US引导下经皮细针穿刺活检(FNAB)未明确诊断。停用左甲状腺素后,血清促甲状腺激素(TSH)>100 mU/L,甲状腺球蛋白为9.4 ng/mL,抗甲状腺球蛋白抗体阴性。诊断性WBS显示脾脏摄取轻度增高,但其他方面无异常。给予192 mCi I(131)治疗后,WBS显示纵隔及脾脏放射性活性增加,提示纵隔和脾脏转移。腹部增强CT显示脾脏多个低密度、不均匀强化肿块,肝脏正常,无腹腔淋巴结肿大。最大肿块(4.5×3.5 cm)为外生性,紧邻脾包膜。尽管血清甲状腺球蛋白仅为9.4 ng/mL,但脾脏实性肿块内I(131)摄取的发现导致术前诊断为甲状腺癌转移。为明确诊断并消除脾破裂风险,进行了腹腔镜脾切除术。组织病理学分析显示为大的沿岸细胞血管瘤(LCA)。已有报道PTC合并椎体血管瘤时放射性碘闪烁显像出现假阳性。据我们所知,这是首例描述多个血管瘤酷似甲状腺癌转移至脾脏的病例。在所有报道病例中,三分之一的LCA与各种内脏器官癌症或恶性淋巴瘤共存。这是LCA与甲状腺癌关联的首例报道。